478
M.E. OJaIMI et al.
dichloromethane/MeOH 98/2). The red fraction was col-
lected and then evaporated to give the title compound in
85% yield (89.5 mg, 0.116 mmol); mp > 300 °C. 1H NMR
(300 MHz; CDCl3; 298 K): δ, ppm -2.49 (br. s, 2H, NH),
1.91 (s, 18H, CH3-mesityl), 2.67 (s, 9H, CH3-mesityl),
7.33 (s, 6H, Hmeta-mesityl), 8.05 (s, 1H, Hmeta-pyridine),
8.46 (s, 1H, Hpara-pyridine), 8.73 (s, 4H, Hβ-porphyrin),
8.82 (s, 4H, Hβ-porphyrin), 9.67 (s, 1H, Hortho-pyridine),
10.51 (s, 1H, aldehyde). UV-vis (CH2Cl2): λmax, nm (log
ε) 419 (5.34), 514 (3.84), 552 (3.84), 591 (3.84), 648
(3.70). MS (MALDI-TOF): m/z 770.34 [M + H]+, 769.38
calcd. for C53H47N5O. HR-MS (ESI): m/z 770.3858
[M + H]+, 770.3859 calcd. for C53H48N5O, 792.3679 [M +
Na]+, 792.3678 calcd. for C53H47N5NaO.
5-(6-formylpyrid-3-yl)-10,15,20-trimesitylpor-
phinato-Zn(II) Zn-(9). Porphyrin Zn-9 was prepared in
78% (485 mg, 0.582 mmol) as a purple compound using
the procedure described above for Zn-8, starting from
5-bromopyridine-2-carbaldehyde (138 mg, 0.755 mmol,
1.1 eq.), Cs2CO3 (424 mg, 1.12 mmol, 1.5 eq.), Pd(OAc)2
(33.4 mg, 0.149 mmol, 0.2 eq.) and P(Ph)3 (116.8 mg,
0.447 mmol, 0.6 eq.), the reaction mixture was heated
5-bromo-2-chloromethyl-pyridine (11). This com-
pound, isolated as a liquid at room temperature, was pre-
pared in 94% (890 mg, 4.34 mmol) using the procedure
described for 3, starting from 10 (864 mg, 4.62 mmol, 1
eq.) and thionyl chloride (1.0 mL, 13.86 mmol, 3 eq.).
1H NMR (300 MHz; CDCl3; 298 K): δ, ppm 4.63 (s, 2H,
CH2-Cl), 7.38 (d, 1H, 3JH-H = 8.3 Hz, Hmeta-pyridine), 7.85
(dd, 1H, 3JH-H = 8.3 Hz, 4JH-H = 2.4 Hz, Hpara-pyridine), 8.63
(d, 1H, 4JH-H = 2.4 Hz, Hortho-pyridine). 13C NMR (75 MHz;
CDCl3; 298 K): δ, ppm 45.9 (CH2-Cl), 120.1 (C5-pyridine),
124.1 (C3-pyridine), 139.7 (C4-pyridine), 150.5 (C6-pyri-
dine), 155.2 (C2-pyridine). GC-MS (EI, 70eV): m/z (%)
204.9 (38) [M]+•, 204.93 calcd. for C6H5BrClN, 169.9.0
(60) [M - Cl]+, 169.96 calcd. for C6H5BrN.
5-(5-bromo-picol-2-yl)-10,15,20-trimesitylporph-
inato-Zn(II) Zn-(12). Porphyrin Zn-12 was prepared
in 78% (284 mg, 0.317 mmol) as a purple compound
using the procedure described for Zn-8, starting from
5-bromo-2-chloromethyl-pyridine 11 (86 mg, 0.42 mmol,
1 eq.), Cs2CO3 (239.5 mg, 0.63 mmol, 1.5 eq.), Pd(OAc)2
(18.9 mg, 0.0084 mmol, 0.2 eq) and P(Ph)3 (65.84 mg,
0.252 mmol, 0.6 eq.), the reaction mixture being heated
at 105 °C for 16 h. mp > 300 °C. UV-vis (CH2Cl2): λmax
,
at 80 °C for 7 h. mp > 300 °C. UV-vis (CH2Cl2): λmax,
nm (log ε) 426 (5.39), 555 (4.08), 601 (3.40). HR-MS
(MALDI-TOF): m/z 831.2897 [M]+•, 831.2916 calcd. for
C53H45N5OZn.
nm (log ε) 422 (5.35), 552 (4.04), 589 (3.40). HR-MS
(MALDI-TOF): m/z 895.2176 [M]+•, 895.2228 calcd. for
C53H46BrN5Zn.
5-(6-formylpyrid-3-yl)-10,15,20-trimesitylporphy-
rin (9). Porphyrin 9 was prepared in 88% (394.19 mg,
0.512 mmol) as a purple compound using the procedure
described above for 8, starting from porphyrin Zn-9 (485
5-(5-bromo-picol-2-yl)-10,15,20-trimesitylporphy-
rin (12). Porphyrin 12 was prepared in 90% (238 mg,
0.285 mmol) as a purple compound using the procedure
described for 8, starting from porphyrin Zn-12 (284 mg,
0.317 mmol). mp > 300 °C. 1H NMR (300 MHz; CDCl3;
298 K): δ, ppm -2.44 (br. s, 2H, NH), 1.88 (s, 18H, CH3-
mesityl), 2.66 (s, 9H, CH3-mesityl), 6.59 (s, 2H, CH2-
1
mg, 0.582 mmol). mp > 300 °C. H NMR (300 MHz;
CDCl3; 298 K): δ, ppm -2.52 (br. s, 2H, NH), 1.87 (s,
18H, CH3-mesityl), 2.64 (s, 9H, CH3-mesityl), 7.31 (s,
3
5
3
6H, Hmeta-mesityl), 8.43 (dd, 1H, JH-H = 7.9 Hz, JH-H
pyridine), 6.64 (d, 1H, JH-H = 8.5 Hz, Hmeta-pyridine),
3
3
= 0.8 Hz, Hmeta-pyridine), 8.69 (d, 6H, JH-H = 4.8 Hz,
7.31 (s, 6H, Hmeta-mesityl), 8.65 (d, 4H, JH-H = 4.9 Hz,
Hβ-porphyrin), 8.72 (dd, 1H, 3JH-H = 7.9 Hz, 4JH-H = 2.0 Hz,
Hpara-pyridine), 8.78 (d, 2H, 3JH-H = 4.8 Hz, Hβ-porphyrin),
Hβ-porphyrin), 8.70 (dd, 1H, 3JH-H = 8.5 Hz, 4JH-H = 2.4 Hz,
Hpara-pyridine), 8.78 (d, 2H, 3JH-H = 4.9 Hz, Hβ-porphyrin),
8.82 (d, 1H, 4JH-H = 2.4 Hz, Hortho-pyridine), 9.42 (d, 2H,
3JH-H = 4.9 Hz, Hβ-porphyrin). UV-vis (CH2Cl2): λmax, nm
(log ε) 418 (5.37), 516 (4.08), 549 (3.70), 593 (3.40), 650
(3.40). MS (MALDI-TOF): m/z 834.31 [M + H]+, 833.31
calcd. for C53H48BrN5. HR-MS (ESI): m/z 834.3166 [M +
H]+, 834.3171 calcd. for C53H49BrN5.
4
5
9.64 (dd, 1H, JH-H = 2.0 Hz, JH-H = 0.8 Hz, Hortho-pyri-
dine), 10.48 (s, 1H, aldehyde). UV-vis (CH2Cl2): λmax, nm
(log ε) 420 (5.32), 516 (3.95), 551 (3.30), 592 (3), 648
(3). MS (MALDI-TOF): m/z 770.41 [M + H]+, 769.38
calcd. for C53H47N5O. HR-MS (ESI): m/z 770.3927 [M +
H]+, 770.3859 calcd. for C53H48N5O.
(5-bromo-pyrid-2-yl)methanol (10). This compound
was prepared in 86% (864 mg, 4.62 mmol) using the pro-
cedure described for 4, starting from 5-bromopicolinal-
dehyde (1.00 g, 5.37 mmol, 1 eq.) and LiAlH4 (122 mg,
3.22 mmol, 0.6 eq.). mp 59–60 °C. 1H NMR (300 MHz;
CDCl3; 298 K): δ, ppm 4.72 (br. s, 1H, OH), 5.22 (s, 2H,
CH2-OH), 7.18 (d, 1H, 3JH-H = 8.3 Hz, Hmeta-pyridine), 7.81
(dd, 1H, 3JH-H = 8.3 Hz, 4JH-H = 2.3 Hz, Hpara-pyridine), 8.63
(d, 1H, 4JH-H = 2.3 Hz, Hortho-pyridine). 13C NMR (75 MHz;
CDCl3; 298 K): δ, ppm 63.9 (CH2-OH), 121.7 (C5-pyri-
dine), 128.8 (C3-pyridine), 139.3 (C4-pyridine), 149.7
(C6-pyridine), 151.1 (C2-pyridine). GC-MS (EI, 70eV):
m/z (%) 187.0 (9) [M]+•, 186.96 calcd. for C6H6BrNO,
156.0 (15) [M - CH2OH]+, 155.94 calcd. for C5H3BrN.
5-(6-methylcarboxylate-pyrid-3-yl)-10,15,20-tri-
mesitylporphinato-Zn(II) (Zn-14). Porphyrin Zn-14
was prepared in 67% (202 mg, 0.235 mmol) as a pur-
ple compound using the procedure described for Zn-8,
starting from methyl-5-bromopyridine-2-carboxylate (82
mg, 0.38 mmol, 1.1 eq.), Cs2CO3 (119 mg, 0.525 mmol,
1.5 eq.), Pd(OAc)2 (15.7 mg, 0.007 mmol, 0.2 eq.) and
P(Ph)3 (54.8 mg, 0.21 mmol, 0.6 eq.), the reaction mix-
ture being heated at 100 °C for 30 h. mp > 300 °C. UV-
vis (CH2Cl2): λmax, nm (log ε) 422 (5.37), 553 (4.04), 593
(3.48). MS (MALDI-TOF): m/z 862.29 [M + H]+, 861.30
calcd. for C54H47N5O2Zn. HR-MS (ESI): m/z 861.2992
[M]+•, 861.3021 calcd. for C54H47N5O2Zn, 884.2884
[M + Na]+, 884.2919 calcd. for C54H47N5NaO2Zn.
Copyright © 2010 World Scientific Publishing Company
J. Porphyrins Phthalocyanines 2010; 14: 478–480